About - Barnik Invest

About us

Barnik Invest Group is more than just an investment company.

Barnik Invest Group: Your Partner in Life Science Innovation

Barnik Invest Group is a pioneering investment firm dedicated to nurturing and growing innovative life science companies in the Nordics. With a deep-rooted history in the industry, we offer a comprehensive suite of services that extends far beyond traditional investment. Our broad approach provides life science companies with the essential tools and resources they need to thrive, from early-stage development to commercialization.

What sets Barnik Invest Group apart is our unique ecosystem, which combines strategic investment with a comprehensive range of services. By leveraging our wholly-owned subsidiaries, Medicorent and StartUpPharma, we offer a 360-degree solution that addresses the multifaceted challenges faced by life science companies. This integrated approach ensures that our portfolio companies receive the support they need to succeed, from early-stage development to commercialization.

Our portfolio companies benefit from our dedicated capital, which fuels their growth and development. Through our Medicorent subsidiary, we offer world-class clinical development services, streamlining trials and accelerating time-to-market. Additionally, we connect our portfolio companies with top-tier talent, enabling them to build high-performing teams. Our experts also help optimize company structures and processes, while our subsidiary, StartUpPharma, provides strategic guidance and networks to facilitate successful market entry.

Company History

May 2010

The parent company CRP Scandinavia AB (CRP) invests in Medicorent

Jan 2012

CRP starts a distribution business (StartUpPharma)

Sep 2013

Medicorent starts a subsidiary in Norway and operations in Denmark

Jan 2015

Barnik Invest AB is registered as a holding company

Jan 2015

Medicorent Int. AB is formed after the acquisition of a consulting business.

Mar 2017

CRP exits all invested companies and acquires Barnik Invest AB, including Medicorent Int. AB

Sep 2019

Barnik Invest AB is restructured from a holding company to an investment company

Sep 2019

Invests in CathPrint AB

Nov 2020

Barnik Invest acquires Sanikma AB

Dec 2020

Sanikma AB changes its name to StartUpPharma Int. AB

Mar 2020

Invests in the online shop Bonimedics.com

May 2021

Invests in Milmed Unico AB

Nov 2021

Joint-Venture project with Dynalis Pharma, Switzerland (Bonipharmex)

Aug 2023

Acquires Idogen’s technology platform

Oct 2023

The portfolio company Cell4Cure AB is founded

Dec 2024

Barnik Holding AB is established as a holding company for all portfolio companies

Invest in the Future of Life Science

By partnering with Barnik Invest Group, you gain access to a wealth of benefits, including diversified investment opportunities, synergistic support, active partnership, industry expertise, and global reach. Our mission is to foster a thriving life science ecosystem in the Nordics by supporting innovative companies and accelerating the development of life-saving therapies. By investing in your success, we are investing in a healthier future for all.

Are you a life science entrepreneur seeking investment and support? Or are you an investor looking for exciting opportunities in the life science sector? Contact us today to learn more about how Barnik Invest Group can help you achieve your goals.

Meet the team

HAMID BAKHSHI

FOUNDER & CEO

HAMID BAKHSHI

Hamid is a visionary and has over 25 years of experience from the life science industry where he has worked both nationally and internationally. He has solid experience in clinical research and held various leading positions at companies such as Pharmacia, Pfizer, Eli Lilly and was CEO at an international CRO company, Parexel. Since 2010, Hamid has founded a number of different companies and has a very broad understanding and experience for the entreprenuial journey and its different development phases. Today, he successfully runs the Barnik Invest group.

Contact Me

SARA NIKMAN

Co-Founder & COO

SARA NIKMAN

Sara has a master in biomedical laboratory science and has over 15 years of experience in the life science industry.A background in preclinical and development phase to clinical research and quality work in the pharmaceutical industry at companies such as Merck, GSK and Sanofi. Furthermore, she is an experienced project manager and is operationally responsible for Medicorent working with recruitment, consulting services and research assigments. Sara runs several companies and is a co-owner of Barnik invest Group.

Contact me

FREDRIK GUSTAVSSON

Business development

FREDRIK GUSTAVSSON

Fredrik is a seasoned business development professional with 15+ years of experience. He's held various roles, including employee, consultant, and entrepreneur. In recent years, Fredrik has focused on the life science industry, leveraging his expertise to help companies raise capital and secure strategic partnerships. He is an active investor in both public and private companies, specializing in life sciences and other sectors with significant growth potential.

Contact me

SEBASTIAN GUEVARA

CFO

SEBASTIAN GUEVARA

As our CFO, Sebastian brings years of experience in accounting and finance. With a keen eye for technological advancements, he's adept at leveraging digital tools to streamline financial operations. Sebastian is committed to providing strategic financial guidance that drives business growth and ensures long-term sustainability.

BENEDICT BROENNIMANN

Chief Scientific Officer

BENEDICT BROENNIMANN

Dr. Benedikt Broennimann, M.D., is a multilingual executive with distinguished 20+ year career reflecting a consistent history of success in delivering strong market, financial, and operational results for companies in the medical device industry. He is an effective and seasoned negotiator and dealmaker with exposure in Europe, the US and Asia. Benedict is a certified specialist in both general surgery and pharmaceutical medicine with over 10 years of clinical experience.